ALBEMARLE CORP
8-K, 1999-04-19
PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS
Previous: PANTRY INC, 8-A12G, 1999-04-19
Next: JP MORGAN SERIES TRUST II, 497, 1999-04-19




                       SECURITIES AND EXCHANGE COMMISSION



                             Washington, D.C. 20549






                                    FORM 8-K


                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported) April 16, 1999
                                                         ---------------



                              Albemarle Corporation
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


          Virginia                       1-12658                54-1692118
- ----------------------------           ------------          -------------------
(State or other jurisdiction           (Commission             (IRS Employer
      of incorporation)                File Number)          Identification No.)



           330 South Fourth Street, Richmond, Virginia        23219
        ----------------------------------------------------------------
            (Address of principal executive offices)        (Zip Code)

Registrant's telephone number, including area code     (804) 788-6000
                                                   ----------------------


<PAGE>

Item 5.  Other Events.


         On March 8, 1999, Albemarle  Corporation (the "Company") announced that
it will offer to  acquire  the  outstanding  shares of  Albright  & Wilson  plc,
headquartered  in London,  tendering  for shares at 130 pence or about $2.08 per
share.

         On April 13, 1999, ISPG PLC offered to acquire the  outstanding  shares
of Albright & Wilson for a price of 145 pence per share.  ISPG is a wholly owned
subsidiary of Donau Chemic AG, a private Austrian  company,  and was formed as a
result of a cooperation  between Donau Chemic and Rhodia, a French company 68.2%
owned by Rhone-Poulenc.

         On April 16,  1999,  the Company  announced  that it will  increase its
offer to acquire  the  outstanding  shares of  Albright & Wilson to 160 pence or
about $2.58 per share. The Company currently holds 18.6 percent of the shares of
Albright & Wilson.  A copy of the press  release  issued by the Company on April
16, 1999, is attached hereto as Exhibit 99.

Item 7.    Exhibits.

Exhibit 99    Press Release of Albemarle Corporation dated April 16, 1999.


                                      -2-
<PAGE>

                                    SIGNATURE


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                      ALBEMARLE CORPORATION
                                       (Registrant)


Date:  April 19, 1999                 By: /s/ E. Whitehead Elmore
                                         --------------------------------------
                                      Name: E. Whitehead Elmore
                                      Title: Senior Vice President


                                      -3-
<PAGE>

                                  Exhibit Index


Exhibit

99      Press Release of Albemarle Corporation dated April 16, 1999.



                                      -4-


                                                                      Exhibit 99


                     Press Release of Albemarle Corporation
                                 April 16, 1999



Albemarle Increases Offer to Acquire Albright & Wilson



RICHMOND,  Va.,  April 16,  1999 --  Albemarle  Corporation  (NYSE:  ALB)  today
announced it is amending its offer to acquire the outstanding shares of Albright
& Wilson  plc,  headquartered  in London.  Based on  Albright & Wilson's  shares
outstanding,  the offer price is approximately $790 million.  The offer has been
recommended by Albright & Wilson's Board of Directors.

Albemarle  currently  holds 18.6  percent of the shares of Albright & Wilson and
has  acceptances  of another  0.69  percent,  representing  approximately  19.29
percent  of the  shares of the  company.  The  acquisition  has been  cleared by
regulatory authorities in the United Kingdom and the United States.

Albright & Wilson is a major United Kingdom specialty and fine chemicals company
with  leadership  positions in  phosphate  chemicals  used in  beverages  and as
detergent builders and in purified  phosphoric acid.  Albright & Wilson operates
in three business areas -- phosphates,  surfactants  and phosphorus  derivatives
and acrylics -- and its annual sales are approximately $1.3 billion.  Albright &
Wilson employs approximately 5,000.

Albemarle  Corporation  has indicated that the  acquisition of Albright & Wilson
will provide the combined  company with the  opportunity  to expand  product and
service  offerings to customers  in the polymer,  pharmaceutical,  agricultural,
cleaning  and  water  treatment  markets.   "The  combination  offers  scale  of
operations,  larger  global  presence  in  both  manufacturing  and  sales,  new
technological  opportunities and new customer  relationships  that will increase
value for our  shareholders,"  said Floyd D. Gottwald,  Jr.,  chairman and chief
executive officer of Albemarle.

The offer will not be made to  Albright &  Wilson's  shareholders  in the United
States, Japan, Canada or Australia.

A global supplier of specialty polymers and fine chemicals that enhance consumer
products,  Albemarle  Corporation  serves markets for polymers,  surfactants and
biocides, pharmachemicals, agricultural chemicals, photographic chemicals, water
treatment and petroleum  products.  Albemarle employs  approximately  2,700. The
company's  Web  site is  www.albemarle.com.  Albright  &  Wilson's  Web  site is
www.albright-wilson.com.

                                      -5-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission